approval · primary record
ATROPINE SULFATE
4 approval events · latest 2026-02-04
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-02-04 |
| Approval events | 4 |
| Brand | ATROPINE SULFATE |
| Sponsor | ACCORD HLTHCARE |
| Route | INTRAVENOUS |
Approval history
4 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-02-04 | FDA | NDA | ATROPINE SULFATE | ACCORD HLTHCARE | INTRAVENOUS |
| 2025-10-28 | FDA | NDA | ENLON-PLUS | PHARMOBEDIENT | INJECTION |
| 2025-09-18 | FDA | NDA | ATROPINE SULFATE | RISING | OPHTHALMIC |
| 2025-07-30 | FDA | NDA | ATROPINE SULFATE | HOSPIRA | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:30:55.800Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:atropine-sulfate
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Atropine Sulfate · compound